FI100249B - Kolmiulotteinen soluviljelmäjärjestelmä - Google Patents

Kolmiulotteinen soluviljelmäjärjestelmä

Info

Publication number
FI100249B
FI100249B FI884783A FI884783A FI100249B FI 100249 B FI100249 B FI 100249B FI 884783 A FI884783 A FI 884783A FI 884783 A FI884783 A FI 884783A FI 100249 B FI100249 B FI 100249B
Authority
FI
Finland
Prior art keywords
bone marrow
cells
cell culture
dimensional cell
vitro
Prior art date
Application number
FI884783A
Other languages
English (en)
Swedish (sv)
Other versions
FI884783A (fi
FI884783A0 (fi
Inventor
Brian A Naughton
Gail K Naughton
Original Assignee
Marrow Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/036,154 external-priority patent/US4721096A/en
Application filed by Marrow Tech Inc filed Critical Marrow Tech Inc
Publication of FI884783A publication Critical patent/FI884783A/fi
Publication of FI884783A0 publication Critical patent/FI884783A0/fi
Application granted granted Critical
Publication of FI100249B publication Critical patent/FI100249B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/0233—Pointed or sharp biopsy instruments
    • A61B10/025—Pointed or sharp biopsy instruments for taking bone, bone marrow or cartilage samples
    • A61B2010/0258—Marrow samples
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
FI884783A 1986-04-18 1988-10-17 Kolmiulotteinen soluviljelmäjärjestelmä FI100249B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85356986A 1986-04-18 1986-04-18
US07/036,154 US4721096A (en) 1986-04-18 1987-04-03 Process for replicating bone marrow in vitro and using the same
US3811087A 1987-04-14 1987-04-14
PCT/US1987/000869 WO1987006120A1 (en) 1986-04-18 1987-04-15 Process for replicating bone marrow

Publications (3)

Publication Number Publication Date
FI884783A FI884783A (fi) 1988-10-17
FI884783A0 FI884783A0 (fi) 1988-10-17
FI100249B true FI100249B (fi) 1997-10-31

Family

ID=27364979

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884783A FI100249B (fi) 1986-04-18 1988-10-17 Kolmiulotteinen soluviljelmäjärjestelmä

Country Status (15)

Country Link
EP (1) EP0309456B1 (fi)
JP (2) JP2857392B2 (fi)
KR (1) KR0142885B1 (fi)
AT (1) ATE127692T1 (fi)
AU (3) AU615414B2 (fi)
BG (1) BG51337A3 (fi)
BR (1) BR8707673A (fi)
DE (1) DE3751519T2 (fi)
DK (1) DK665687A (fi)
FI (1) FI100249B (fi)
HK (1) HK1007684A1 (fi)
HU (1) HU202578B (fi)
NO (1) NO179181C (fi)
RO (1) RO106655B1 (fi)
WO (1) WO1987006120A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
AU644578B2 (en) * 1986-04-18 1993-12-16 Marrow-Tech Incorporated Three-dimensional cell and tissue culture system
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US6309635B1 (en) 1986-11-20 2001-10-30 Children's Medical Center Corp. Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
WO1993007913A1 (en) * 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US7214654B1 (en) 1994-12-07 2007-05-08 Karlheinz Schmidt Agent for the manufacture of biological parts including an active ingredient complex and carrying materials suitable for the active ingredient complex
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5741685A (en) * 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
CA2351889A1 (en) * 1998-11-12 2000-05-18 Cell Science Therapeutics, Inc. Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
ES2338405T3 (es) * 1999-02-04 2010-05-07 Pluristem Ltd. Metodo y aparato para mantenimiento y expasion de celulas madre hemopoyeticas y/o celulas progenitoras.
JP2003525602A (ja) 2000-03-02 2003-09-02 ユニバーシティー オブ ロチェスター 三次元バイオリアクターにおける、機能的な白血病細胞のエキソビボ産生
DE10203644A1 (de) * 2002-01-30 2003-08-07 Fraunhofer Ges Forschung Kryokonservierung an textilen Geweben
AU2005215211B2 (en) 2004-02-13 2011-11-03 Smith & Nephew Orthopaedics Ag Wound healing profile
US20080241870A1 (en) * 2005-03-01 2008-10-02 National Centre For Cell Scineces Composition For Creating an Artificial Bone Marrow Like Environment and Use Thereof
JP4977854B2 (ja) * 2005-10-21 2012-07-18 国立大学法人名古屋大学 組織形成用複合材料およびその製造方法
EP2350259A4 (en) * 2008-10-22 2013-12-18 Regenemed Inc CULTURE SYSTEMS
RU2631807C2 (ru) * 2011-06-02 2017-09-26 Президент Энд Феллоуз Ов Харвард Колледж Способы и применение систем культуры ткани ex vivo

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
US4144126A (en) * 1975-05-21 1979-03-13 Beecham Group Limited Cell culture method
JPS51151384A (en) * 1975-06-20 1976-12-25 Olympus Optical Co Ltd Process for cultivating organic tissue or cells automatically
US4024020A (en) * 1975-12-15 1977-05-17 Monsanto Company Method of cell culture on polyacrylonitrile surface
US4184922A (en) * 1977-11-11 1980-01-22 The Government Of The United States Dual circuit, woven artificial capillary bundle for cell culture
US4228243A (en) * 1978-07-13 1980-10-14 Toray Industries, Inc. Cell culture propagation apparatus
IL74715A0 (en) * 1984-03-27 1985-06-30 Univ New Jersey Med Biodegradable matrix and methods for producing same

Also Published As

Publication number Publication date
NO875286D0 (no) 1987-12-17
FI884783A (fi) 1988-10-17
DK665687D0 (da) 1987-12-17
NO179181B (no) 1996-05-13
HK1007684A1 (en) 1999-04-23
EP0309456A1 (en) 1989-04-05
EP0309456B1 (en) 1995-09-13
BG51337A3 (en) 1993-04-15
FI884783A0 (fi) 1988-10-17
DK665687A (da) 1987-12-17
EP0309456A4 (en) 1989-06-27
HUT48112A (en) 1989-05-29
JPH01503195A (ja) 1989-11-02
JP2857392B2 (ja) 1999-02-17
BR8707673A (pt) 1989-08-15
RO106655B1 (ro) 1993-06-30
AU6816090A (en) 1991-03-14
KR0142885B1 (ko) 1998-07-15
NO179181C (no) 1996-08-21
AU615414B2 (en) 1991-10-03
DE3751519T2 (de) 1996-03-28
AU6815990A (en) 1991-03-14
AU7356887A (en) 1987-11-09
JPH10114664A (ja) 1998-05-06
NO875286L (no) 1987-12-17
HU202578B (en) 1991-03-28
ATE127692T1 (de) 1995-09-15
DE3751519D1 (de) 1995-10-19
KR880701093A (ko) 1988-07-25
JP3032492B2 (ja) 2000-04-17
WO1987006120A1 (en) 1987-10-22

Similar Documents

Publication Publication Date Title
FI100249B (fi) Kolmiulotteinen soluviljelmäjärjestelmä
DK161011C (da) Praeparat til kontinuerlig frigivelse af naeringsstoffer og/eller terapeutiske stoffer til droevtyggere samt fremgangsmaade til fremstilling heraf
DE3684462D1 (de) Trennverfahren fuer motile saatzellen in vitro, befruchtungsverfahren und durchdringungsmedium fuer saatzellen.
YU44066B (en) Process for preparing a new poly (lactid-co-glycolyd)-polymer
DE3783356T2 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
JPS6470415A (en) Skin permeable remedy system
HUT47601A (en) Process for releasing cell-mixtures and tissues from non-desirable population
NO980005D0 (no) Terapautiske midler og autoimmunsykdommer
WO2003054150A3 (en) Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
DE69026087D1 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DE69633494D1 (de) Verfahren zur verhinderung von transplantatabstossung
Frodl et al. Effects of hibernation or cryopreservation on the survival and integration of striatal grafts placed in the ibotenate-lesioned rat caudate-putamen
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
ATE2272T1 (de) 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2b)thiophen-4,9-imine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DK163195C (da) Fremgangsmaade til radioaktiv maerkning af blodceller, oploesning til brug ved fremgangsmaaden, fremgangsmaade til fremstilling af oploesningen, og saet til radioaktiv maerkning af blodceller
Fung et al. Alternatives to using fetal tissue from induced abortions
BR9809996A (pt) Processo de preparação de embrião de equinos em vista de sua crioconservação
Hofmann et al. Limb regeneration from X-irradiated tails of Ambystoma mexicanum following transplantation of flank skin from region adjacent to hindlimb
BG48924A3 (en) Method for preparing of biologically active means
DK197091A (da) Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater
UA8360A (uk) Спосіб активації цітотоксичних клітин

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MARROW-TECH INCORPORATED